Category: Research kits

Active filters

  • Brand: Agrisera
  • Brand: Biosensis
  • Brand: Invent
  • Brand: Krishgen
  • Brand: Microzone
  • Brand: SignalChem Diagnostics

Genotyping Kit

Reference: 2GTK-100

DNA Extraction: A fast, easy, single tube lysis, producing quality, PCR ready, DNA in 15 minutes. Amplification: Using Microzone’s 2x MegaMix-GT PCR Mastermix that includes an enhanced PCR reaction buffer, dNTPs and an inert blue loading dye to enable direct gel loading post PCR. Suitable for all templates including GC rich. Enough DNA for numerous typings.

Genotyping Kit

Reference: 2GTK-250

DNA Extraction: A fast, easy, single tube lysis, producing quality, PCR ready, DNA in 15 minutes. Amplification: Using Microzone’s 2x MegaMix-GT PCR Mastermix that includes an enhanced PCR reaction buffer, dNTPs and an inert blue loading dye to enable direct gel loading post PCR. Suitable for all templates including GC rich. Enough DNA for numerous typings.

Genotyping Kit

Reference: 2GTK-500

DNA Extraction: A fast, easy, single tube lysis, producing quality, PCR ready, DNA in 15 minutes. Amplification: Using Microzone’s 2x MegaMix-GT PCR Mastermix that includes an enhanced PCR reaction buffer, dNTPs and an inert blue loading dye to enable direct gel loading post PCR. Suitable for all templates including GC rich. Enough DNA for numerous typings.

TrkB (pS478) Positive Control Cell Lysate (Mouse NSC-34)-50 µg

Reference: CL-2107-50

This cell lysate is suitable as positive control for Western Blotting, to confirm TrkB phosphorylation at amino acid S478 (rat/mouse) or S479 (human), respectively, using TrkB (pS478/479) rabbit antibody R-1718-50. It is particular useful for complex Western Blotting samples to identify TrkB (pS478/479) immunoreactive bands. This lysate has been prepared by triggering TrkB phosphorylation in retinoic acid-treated mouse NSC34 cells with mature BDNF, and subsequent processing with RIPA buffer. The cell lysate is provided lyophilised for extended stability.

KRISHZYME™ Heparin Factor IIa Assay Kit

Reference: KBBA03S

Chromogenic assay for testing Heparins (UFH) in purified systems by measurement of Factor IIa inhibition, in compliance with EP Pharmacopoeia. About the kit: Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity, Recovery rates are between 85 - 115%, Ready to use with a standard protocol with break-apart pre-coated wells, Validated as per US FDA guidelines for Bioassays, Optimized for matrix effects to ensure higher sensitivity, Shelf life: 1 year. The inhibitory effect of Anti-Thrombin III (AT-III) on thrombin (Factor IIa) and other coagulation serine proteases in plasma is increased several thousand-fold by heparin. This inhibition accounts for the anticoagulant effect of heparin. The quantitative determination of heparin levels by the measurement of their Anti-IIa activity is a necessary tool for monitoring treatment efficacy. Unfractionated heparin (UFH) catalyzes both reactions equally. The Factor IIa inhibition test is the most useful assay covering the widest variety of heparin preparations. In the assay, the rate of Factor IIa inhibition is directly proportional to the heparin concentration since both Factor IIa and AT-III are in excess. The residual factor IIa activity is inversely proportional to the heparin concentration.

KRISHZYME™ Heparin Factor Xa Assay Kit

Reference: KBBA04S

Chromogenic assay for testing Heparins (UFH) in purified systems by measurement of Factor Xa inhibition, in compliance with EP Pharmacopoeia. About the kit: Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity, Recovery rates are between 85 - 115%, Ready to use with a standard protocol with break-apart pre-coated wells, Validated as per US FDA guidelines for Bioassays, Optimized for matrix effects to ensure higher sensitivity, Shelf life: 1 year. The inhibitory effect of Anti-Thrombin III (AT-III) on thrombin (Factor Xa) and other coagulation serine proteases in plasma is increased several thousand-fold by heparin. This inhibition accounts for the anticoagulant effect of heparin. The quantitative determination of heparin levels by the measurement of their Anti-Xa activity is a necessary tool for monitoring treatment efficacy. Unfractionated heparin (UFH) catalyzes both reactions equally. The Factor Xa inhibition test is the most useful assay covering the widest variety of heparin preparations. In the assay, the rate of Factor Xa inhibition is directly proportional to the heparin concentration since both Factor Xa and AT-III are in excess. The residual Factor Xa activity is inversely proportional to the heparin concentration.

KRISHZYME™ Enoxaparin Factor IIa Assay Kit

Reference: KBBA03ES

Chromogenic assay for testing Enoxaparin in purified systems by measurement of factor IIa inhibition, in compliance with pharmacopoeias (EP/BP) and FDA guidelines About the kit: Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity, Recovery rates are between 85 - 115%, Ready to use with a standard protocol with break-apart pre-coated wells, Validated as per US FDA guidelines for Bioassays, Optimized for matrix effects to ensure higher sensitivity, Shelf life: 1 year. The inhibitory effect of anti-thrombin III (AT-III) on thrombin, factor IIa and other coagulation serine proteases in plasma is increased several thousand-fold by enoxaparin. This inhibition accounts for the anticoagulant effect of enoxaparin. The quantitative determination of enoxaparin levels by the measurement of their anti-IIa activity is a necessary tool for monitoring treatment efficacy. Presence of Enoxaparin catalyzes the reaction between AT lll and α-Thrombin. The factor IIa inhibition test is the most useful assay covering the widest variety of enoxaparin preparations. In the assay, the rate of factor IIa inhibition is directly proportional to the enoxaparin concentration since both factor IIa and AT-III are in excess. The residual factor IIa activity is inversely proportional to the enoxaparin concentration.

KRISHZYME™ Enoxaparin Factor Xa Assay Kit

Reference: KBBA04ES

Chromogenic assay for testing Enoxaparin in purified systems by measurement of factor Xa inhibition, in compliance with pharmacopoeias (EP/BP) and FDA guidelines About the kit: Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity, Recovery rates are between 85 - 115%, Ready to use with a standard protocol with break-apart pre-coated wells, Validated as per US FDA guidelines for Bioassays, Optimized for matrix effects to ensure higher sensitivity, Shelf life: 1 year. The inhibitory effect of anti-thrombin III (AT-III) on thrombin, factor Xa and other coagulation serine proteases in plasma is increased several thousand-fold by enoxaparin. This inhibition accounts for the anticoagulant effect of enoxaparin. The quantitative determination of enoxaparin levels by the measurement of their anti-Xa activity is a necessary tool for monitoring treatment efficacy. Presence of Enoxaparin catalyzes the reaction between ATlll and Factor Xa. The factor Xa inhibition test is the most useful assay covering the widest variety of enoxaparin preparations. In the assay, the rate of factor Xa inhibition is directly proportional to the enoxaparin concentration since both factor Xa and AT-III are in excess. The residual factor Xa activity is inversely proportional to the enoxaparin concentration.

Back to top